Are Cis-spliced Fusion Proteins Pathological in More Aggressive Luminal Breast Cancer?

Overview

Journal Oncotarget

Specialty Oncology

Date 2023 Jun 12

PMID 37306551

Authors

Chia-Chia Liu

Xiao-Song Wang

Affiliations

Soon will be listed here.

References

Jia Y, Xie Z, Li H . Intergenically Spliced Chimeric RNAs in Cancer. Trends Cancer. 2017; 2(9):475-484. PMC: 5305119. DOI: 10.1016/j.trecan.2016.07.006. View

Taniue K, Akimitsu N . Fusion Genes and RNAs in Cancer Development. Noncoding RNA. 2021; 7(1). PMC: 7931065. DOI: 10.3390/ncrna7010010. View

Zhang Y, Gong M, Yuan H, Park H, Frierson H, Li H . Chimeric transcript generated by cis-splicing of adjacent genes regulates prostate cancer cell proliferation. Cancer Discov. 2012; 2(7):598-607. DOI: 10.1158/2159-8290.CD-12-0042. View

Veeraraghavan J, Tan Y, Cao X, Kim J, Wang X, Chamness G . Recurrent ESR1-CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancers. Nat Commun. 2014; 5:4577. PMC: 4130357. DOI: 10.1038/ncomms5577. View

Brunetti M, Agostini A, Davidson B, Trope C, Heim S, Panagopoulos I . Recurrent fusion transcripts in squamous cell carcinomas of the vulva. Oncotarget. 2017; 8(10):16843-16850. PMC: 5370005. DOI: 10.18632/oncotarget.15167. View

Liu C, Veeraraghavan J, Tan Y, Kim J, Wang X, Loo S . A Novel Neoplastic Fusion Transcript, , Confers Sensitivity to the MEK Inhibitor Trametinib in Aggressive Breast Cancers. Clin Cancer Res. 2020; 27(3):785-798. PMC: 7934498. DOI: 10.1158/1078-0432.CCR-20-2769. View

Li L, Lin L, Veeraraghavan J, Hu Y, Wang X, Lee S . Therapeutic role of recurrent ESR1-CCDC170 gene fusions in breast cancer endocrine resistance. Breast Cancer Res. 2020; 22(1):84. PMC: 7414578. DOI: 10.1186/s13058-020-01325-3. View

Loo S, Yates M, Yang S, Oesterreich S, Lee A, Wang X . Fusion-associated carcinomas of the breast: Diagnostic, prognostic, and therapeutic significance. Genes Chromosomes Cancer. 2022; 61(5):261-273. PMC: 8930468. DOI: 10.1002/gcc.23029. View

Kanoni S, Graham S, Wang Y, Surakka I, Ramdas S, Zhu X . Implicating genes, pleiotropy, and sexual dimorphism at blood lipid loci through multi-ancestry meta-analysis. Genome Biol. 2022; 23(1):268. PMC: 9793579. DOI: 10.1186/s13059-022-02837-1. View

10.

Scaravilli M, Koivukoski S, Latonen L . Androgen-Driven Fusion Genes and Chimeric Transcripts in Prostate Cancer. Front Cell Dev Biol. 2021; 9:623809. PMC: 7900491. DOI: 10.3389/fcell.2021.623809. View

11.

Varley K, Gertz J, Roberts B, Davis N, Bowling K, Kirby M . Recurrent read-through fusion transcripts in breast cancer. Breast Cancer Res Treat. 2014; 146(2):287-97. PMC: 4085473. DOI: 10.1007/s10549-014-3019-2. View

12.

Lee S, Hu Y, Loo S, Tan Y, Bhargava R, Lewis M . Landscape analysis of adjacent gene rearrangements reveals BCL2L14-ETV6 gene fusions in more aggressive triple-negative breast cancer. Proc Natl Acad Sci U S A. 2020; 117(18):9912-9921. PMC: 7211963. DOI: 10.1073/pnas.1921333117. View

13.

Soda M, Choi Y, Enomoto M, Takada S, Yamashita Y, Ishikawa S . Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007; 448(7153):561-6. DOI: 10.1038/nature05945. View